BtHCROSS 2.0%

• High projection capacity and structural support.

• Effective correction of lost facial volume.

• Precise redefinition of facial contours.

• Excellent balance between firmness and tissue integration.

• Adapts to dynamic areas of the face while maintaining natural-looking results.

• Lasts up to 9 months.

• Very low endotoxin level (≤ 0.20 EU/mL).

• BDDE residues below 2 ppm.

• Manufactured in Europe under rigorous quality standards.

• SARE Technology for greater stability, efficacy and clinical durability.

Restoration of facial volume and redefinition of contours. Indicated for facial contouring treatments of the cheekbones, cheeks, chin and jawline, as well as for correcting deep folds and restoring facial support.

• Volume restoration. Effectively compensates for age-related volume loss, restoring support and structure to the face.

• Contour definition. Allows key areas such as the cheekbones, chin and jawline to be sculpted and redefined to improve facial harmony.

• High support capacity. Its rheological profile provides excellent lifting capacity for facial contouring treatments.

• Natural integration. Adapts to the face's natural movements while maintaining a balanced, natural appearance.

• Optimised durability. The combination of homogeneous cross-linking, enzymatic resistance and SARE Technology promotes visible, long-lasting results.

The amount of product to be injected will be determined by the specialist physician based on the area to be treated and the desired level of correction. After the first treatment session, several touch-up and/or repeat sessions may be required to achieve the desired correction. Treatment sessions should not be repeated at intervals of less than fifteen days.

SARE Technology

An innovative hyaluronic acid cross-linking method that delivers unique results through a highly homogeneous cross-linking process.

A proprietary combination of low- and high-molecular-weight hyaluronic acid that creates a polymer matrix with a low degree of modification.